phenacemide ๐Ÿถ Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
2114 63-98-9

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • phenuron
  • phenacemide
  • cetylureum
  • fenacemid
  • neophedan
  • phacetur
  • phenacalum
  • phenacetur
  • phenacetylcarbamide
  • phenacetylurea
  • phenicarb
  • phetylureum
  • phenurone
Phenacemide (Phenurone) is an older antiepileptic agent. It is capable of relieving patients resistant to other antiepileptics, although its therapeutic effectiveness must be balanced against its toxic effects.
  • Molecular weight: 178.19
  • Formula: C9H10N2O2
  • CLOGP: 0.87
  • LIPINSKI: 0
  • HAC: 4
  • HDO: 2
  • TPSA: 72.19
  • ALOGS: -2.23
  • ROTB: 2

  • Status: OFM

  • Legend:
    OFP - off patent
    OFM - off market
    ONP - on patent

Drug dosage:

DoseUnitRoute
1.50 g O

ADMET properties:

PropertyValueReference
MRTD (Maximum Recommended Therapeutic Daily Dose) 280.60 ยตM/kg/day Contrera JF, Matthews EJ, Kruhlak NL, Benz RD

Approvals:

DateAgencyCompanyOrphan
June 28, 1951 FDA ABBVIE

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
ATC N03AX07 NERVOUS SYSTEM
ANTIEPILEPTICS
ANTIEPILEPTICS
Other antiepileptics

Drug Use | Suggest Off label Use Form| |View source of the data|

DiseaseRelationSNOMED_IDDOID
Epilepsy indication 84757009 DOID:1826
Epilepsy characterized by intractable complex partial seizures indication 442481002




๐Ÿถ Veterinary Drug Use

None

๐Ÿถ Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation levelDissociation constantType (acidic/basic)
pKa1 12.1 acidic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

TargetClassPharosUniProtActionTypeActivity value
(-log[M])
Mechanism
action
Bioact sourceMoA source
Sodium channel protein type 1 subunit alpha Ion channel BLOCKER WOMBAT-PK

External reference:

IDSource
4018717 VUID
N0000147023 NUI
D00504 KEGG_DRUG
4018717 VANDF
C0070525 UMLSCUI
CHEBI:8049 CHEBI
CHEMBL918 ChEMBL_ID
DB01121 DRUGBANK_ID
4753 PUBCHEM_CID
92 INN_ID
C005396 MESH_SUPPLEMENTAL_RECORD_UI
7265 IUPHAR_LIGAND_ID
PAI7J52V09 UNII
204310 RXNORM
1302 MMSL
5265 MMSL
d00947 MMSL
001632 NDDF
18712002 SNOMEDCT_US
400358006 SNOMEDCT_US

Pharmaceutical products:

None